TCD Capital

myNEO Therapeutics' CEO Cedric Bogaert receives the Medical Genetics award at the Vatican

Cedric Bogaert, CEO of myNEO Therapeutics

Cedric Bogaert, CEO of myNEO Therapeutics, received the Medical Genetics award at the Vexillum Sciacca Awards in the Vatican.

The award recognises the work of the myNEO Therapeutics team, which has also presented its research on neoantigen discovery at several conferences and panel discussions in recent months.